{
  "nctId": "NCT04863898",
  "briefTitle": "Addressing Drug Use Stigma in Human Immunodeficiency Virus (HIV) Care and Treatment Clinics in Tanzania",
  "officialTitle": "Improving HIV Treatment Outcomes for People Who Use Drugs: Adapting and Piloting a Drug-use Use Stigma-reduction Intervention in HIV Care and Treatment Clinics in Tanzania",
  "protocolDocument": {
    "nctId": "NCT04863898",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2021-03-08",
    "uploadDate": "2023-09-19T22:53",
    "size": 228297,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04863898/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 151,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2021-02-17",
    "completionDate": "2022-07-01",
    "primaryCompletionDate": "2022-07-01",
    "firstSubmitDate": "2021-03-29",
    "firstPostDate": "2021-04-28"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\nIntervention pilot testing phase:\n\n-This will include CTC staff and other staff within the medical facility where the CTC is physically housed who come into direct contact with clients attending the CTC (guards, receptionists, lab and pharmacy staff), who work in one of the seven clinics selected for this study.\n\nExclusion Criteria:\n\n* Under the age of 18.\n* Refusal to Consent.\n* PLWH participants who appear to be too impaired to provide informed consent or answer questions accurately will be ineligible.",
    "healthyVolunteers": true,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Modified Opening Minds Scale for Health Providers (OMS-HC)",
        "description": "8-item scale measuring stigma in staff (study participants) working in HIV clinics toward people who use drugs. 5-point Likert scale: 5 indicating the highest degree of agreement with the statement. The score is calculated additively with a range of 8-40. Higher scores indicate a higher level of stigma.\n\nIncluded items\n\n* If I were under treatment for drug addiction, I would not disclose this to any of my colleagues.\n* If I had drug addiction, I would seek treatment at a health facility away from the one I work in.\n* I would see myself as weak if I had drug addiction and could not fix it myself\n* I would be reluctant to seek help if I had drug addiction\n* Despite my professional beliefs, I have negative reactions towards people who use drugs\n* I would not want a person with addiction, even if it were managed, to work with children.\n* Healthcare providers do not need to be advocates for people who use drugs.\n* I am afraid to provide health services to people who use drugs",
        "timeFrame": "Baseline survey (weeks 1-3) and Endline Survey (weeks 17-24, 3 months after participant had completed training)"
      },
      {
        "measure": "Feasibility of Intervention Measure",
        "description": "A 4-item scale that measures staff's (study participants') perception of the feasibility of the intervention in their context. Each item consists of a 5-point Likert scale, with 5 indicating the highest degree of agreement with the item. The score is calculated by taking the mean of the responses. Scores range from 1-5. Higher values correspond to a higher degree of agreement that the intervention is feasible in the respondent's context.. The questions are:\n\n1. (INSERT INTERVENTION) seems implementable.\n2. (INSERT INTERVENTION) seems possible.\n3. (INSERT INTERVENTION) seems doable.\n4. (INSERT INTERVENTION) seems easy to use.",
        "timeFrame": "Endline Survey (weeks 17-24, 3 months after participant had completed training)"
      },
      {
        "measure": "Acceptability of Intervention Measure",
        "description": "A 4-item scale that measures the degree to which staff (study participants) find the intervention acceptable. Each item consists of a 5-point Likert scale, with 5 indicating the highest degree of agreement with the item. The score is calculated by taking the mean of the responses. Scores range from 1-5. Higher values correspond to a higher degree of agreement that the intervention is acceptable to the respondent. The questions are:\n\n1. (INSERT INTERVENTION) meets my approval.\n2. (INSERT INTERVENTION) is appealing to me.\n3. I like (INSERT INTERVENTION).\n4. I welcome (INSERT INTERVENTION).",
        "timeFrame": "Endline Survey (weeks 17-24, 3 months after participant had completed training)"
      },
      {
        "measure": "Appropriateness of Intervention Measure",
        "description": "A 4-item scale that measures the degree to which staff (study participants) find the intervention acceptable. Each item consists of a 5-point Likert scale, with 5 indicating the highest degree of agreement with the item. The score is calculated by taking the mean of the responses. Scores range from 1-5. Higher values correspond to a higher degree of agreement that the intervention is acceptable to the respondent. The questions are:\n\n1. (INSERT INTERVENTION) seems fitting.\n2. (INSERT INTERVENTION) seems suitable.\n3. (INSERT INTERVENTION) seems applicable.\n4. (INSERT INTERVENTION) seems like a good match.",
        "timeFrame": "Endline Survey (weeks 17-24, 3 months after participant had completed training)"
      }
    ],
    "secondary": [
      {
        "measure": "Knowledge About Drug Use and How to Provide HIV Services to People Who Use Drugs",
        "description": "Self-reported knowledge. Likert scale (1-5): 8-10 items (2 additional items for clinical staff (CS)). Scores (range:1-5), calculated by taking the mean value of responses to all questions. Higher scores correspond to higher degrees of knowledge and therefore a better outcome.\n\nItems\n\n* I feel\n\n  * I have a working knowledge of drugs and drug related problems.\n  * safe providing HIV services to people who use drugs (PWUD)\n* I feel I know enough about {insert below item} to carry out my role providing HIV services to PWUD\n\n  * the causes of drug problems\n  * the physical effects of drug use\n  * the psychological effects of drugs\n  * the factors which put people at risk of developing drug problems\n* I feel I know enough about {insert below item} to provide appropriate services to PWUD\n\n  * drug addiction as a brain disease\n  * the social effects of drug use\n  * drug-to drug interactions (CS only)\n  * co-occurring conditions (CS only)",
        "timeFrame": "Baseline survey (weeks 1-3) and Endline Survey (weeks 17-24, 3 months after participant had completed training)"
      },
      {
        "measure": "Modified Bogardus Social Distance Scale",
        "description": "6-item scale measuring social distance, or (un)willingness to interact with a person who uses drugs in different social interactions. 4-point Likert scale, with 4 indicating a response of \"definitely yes\" and 1 indicating \"definitely no\". The score is calculated additively with a range of 6-24. Higher scores correspond to higher degrees of social distance and therefore a worse outcome.\n\nIncluded items\n\n* Would you feel ashamed if people knew someone in your family has drug addiction?\n* Would you be afraid to have a conversation with someone who uses drugs?\n* Would you be disturbed about working at the same health facility with someone who uses drugs?\n* Would you stop being friends with someone who uses drugs?\n* Would you feel upset or disturbed being in the same room with someone who uses drugs?\n* Would you marry someone who uses drugs? (reverse coded)",
        "timeFrame": "Baseline survey (weeks 1-3) and Endline Survey (weeks 17-24, 3 months after participant had completed training)"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 4,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 6
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 54,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:30:20.005Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}